TrialBMC infectious diseases2018

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults.

Judith Kirstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.